Pfizer Says Booster Strengthens Immune Response for Children 5 to 11
Pfizer and BioNTech will soon ask the Food and Drug Administration for emergency authorization of Covid booster doses for that age group, the companies said.
Source: NYT - Category: American Health Authors: Sharon LaFraniere Tags: Pfizer Inc BioNTech SE Coronavirus (2019-nCoV) Vaccination and Immunization Coronavirus Omicron Variant Children and Childhood Drugs (Pharmaceuticals) Food and Drug Administration Source Type: news
More News: American Health | Children | Coronavirus | Covid Vaccine | COVID-19 | Emergency Medicine | Food and Drug Administration (FDA) | Pfizer | Vaccines